POTASSIUM CITRATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for potassium citrate and what is the scope of freedom to operate?

Potassium citrate is the generic ingredient in two branded drugs marketed by Ut Sw Medctr, Ani Pharms, Ascent Pharms Inc, Bionpharma, Hibrow Hlthcare, Rising, Strides Pharma, Teva Pharms Usa Inc, Torrent, Zydus Pharms, and Mission Pharma, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for potassium citrate. Sixteen suppliers are listed for this compound.

Summary for POTASSIUM CITRATE

US Patents:	0
Tradenames:	2
Applicants:	11
NDAs:	11
Drug Master File Entries:	4
Finished Product Suppliers / Packagers:	16
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	62
Patent Applications:	5,709
Drug Prices:	Drug price trends for POTASSIUM CITRATE
What excipients (inactive ingredients) are in POTASSIUM CITRATE?	POTASSIUM CITRATE excipients list
DailyMed Link:	POTASSIUM CITRATE at DailyMed

See drug prices for POTASSIUM CITRATE

Recent Clinical Trials for POTASSIUM CITRATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Albert Einstein College of Medicine	Phase 2/Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 2/Phase 3
University of Utah	Phase 2/Phase 3

See all POTASSIUM CITRATE clinical trials

Pharmacology for POTASSIUM CITRATE

Drug Class	Anti-coagulant Calculi Dissolution Agent
Mechanism of Action	Acidifying Activity Calcium Chelating Activity
Physiological Effect	Decreased Coagulation Factor Activity

Medical Subject Heading (MeSH) Categories for POTASSIUM CITRATE

Diuretics
Expectorants

Anatomical Therapeutic Chemical (ATC) Classes for POTASSIUM CITRATE

A12BA	Potassium
A12B	POTASSIUM
A12	MINERAL SUPPLEMENTS
A	Alimentary tract and metabolism

US Patents and Regulatory Information for POTASSIUM CITRATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hibrow Hlthcare	POTASSIUM CITRATE	potassium citrate	TABLET, EXTENDED RELEASE;ORAL	214426-002	Feb 19, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mission Pharma	UROCIT-K	potassium citrate	TABLET, EXTENDED RELEASE;ORAL	019071-003	Dec 30, 2009	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mission Pharma	UROCIT-K	potassium citrate	TABLET, EXTENDED RELEASE;ORAL	019071-002	Aug 31, 1992	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.